With 1.15 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.96 million shares. The 52-week range on PCRX shows that it touched its highest point at $31.67 and its lowest point at $11.16 during that stretch. It currently has a 1-year price target of $36.17. Beta for the stock currently stands at 0.52.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PCRX was up-trending over the past week, with a rise of 2.95%, but this was up by 5.68% over a month. Three-month performance surged to 1.65% while six-month performance rose 53.93%. The stock lost -16.09% in the past year, while it has gained 37.26% so far this year. A look at the trailing 12-month EPS for PCRX yields -2.29 with Next year EPS estimates of 3.43. For the next quarter, that number is 0.69. This implies an EPS growth rate of -11.38% for this year and 20.81% for next year. EPS is expected to grow by 11.67% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -51.99%.
Float and Shares Shorts:
At present, 46.28 million PCRX shares are outstanding with a float of 44.27 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PCRX since 6 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $3.46578 being high and $3.01157 being low. For PCRX, this leads to a yearly average estimate of $3.14981.
